Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

20 results
Display

Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016

Stickel F, Datz C, Hampe J, Bataller R

  • Gut Liver.
  • 2017 May;11(3):447-447.
  • doi: 10.5009/gnl11031
Page 178, Fig. 3: The following note should be included as the last line of the figure legend.
Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction

Kim JY, Ko GB, Lee TH, Park SH, Lee YN, Cho YS, Jung Y, Chung IK, Choi HJ, Cha SW, Moon JH, Cho YD, Kim SJ

  • Gut Liver.
  • 2017 May;11(3):440-446.
  • doi: 10.5009/gnl16245
BACKGROUND/AIMS: Controversy still exists regarding the benefits of covered self-expandable metal stents (SEMSs) compared to uncovered SEMSs. We aimed to compare the patency and stent-related adverse events of partially covered...
The Role of Endoscopic Biliary Drainage without Sphincterotomy in Gallstone Patients with Cholangitis and Suspected Common Bile Duct Stones Not Detected by Cholangiogram or Intraductal Ultrasonography

Goong HJ, Moon JH, Lee YN, Choi HJ, Choi SY, Choi MH, Kim MJ, Lee TH, Park SH, Lee HK

  • Gut Liver.
  • 2017 May;11(3):434-439.
  • doi: 10.5009/gnl16234
BACKGROUND/AIMS: Treatment for cholangitis without common bile duct (CBD) stones has not been established in patients with gallstones. We investigated the usefulness of endoscopic biliary drainage (EBD) without endoscopic sphincterotomy...
Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea

Baeg JY, Kim IH, Seo SY, Kim YS, Jung EU, Cho J, Chung JW, Jang ES, Kim JW, Jeong SH

  • Gut Liver.
  • 2017 May;11(3):426-433.
  • doi: 10.5009/gnl16242
BACKGROUND/AIMS: The association between depression and chronic hepatitis C virus (HCV) infection or pegylated interferon α and ribavirin therapy (PR therapy) has not been extensively studied in Korea. We aimed...
Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients

Yim SY, Kim TH, Jun SS, Kim ES, Keum B, Seo YS, Yim HJ, Jeen YT, Chun HJ, Lee HS, Um SH, Kim CD, Won NH, Ryu HS

  • Gut Liver.
  • 2017 May;11(3):417-425.
  • doi: 10.5009/gnl16148
BACKGROUND/AIMS: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B...
Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma

Jeong SO, Kim EB, Jeong SW, Jang JY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim YJ, Goo DE, Park SY

  • Gut Liver.
  • 2017 May;11(3):409-416.
  • doi: 10.5009/gnl16001
BACKGROUND/AIMS: To investigate the predictive factors for complete response (CR) and recurrence after CR in patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE). METHODS: Among 691 newly diagnosed HCC...
Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B

Hennedige , Wang G, Leung FP, Alsaif HS, Teo LL, Lim SG, Wee A, Venkatesh

  • Gut Liver.
  • 2017 May;11(3):401-408.
  • doi: 10.5009/gnl16079
BACKGROUND/AIMS: Comparison of the accuracy of magnetic resonance elastography (MRE) and diffusion weighted imaging (DWI) for the diagnosis of liver fibrosis in patients with chronic hepatitis B (CHB). METHODS: In this...
Expression of MicroRNA in Host Cells Infected with Helicobacter pylori

Chung JW, Jeong SH, Lee SM, Pak JH, Lee GH, Jeong JY, Kim JH

  • Gut Liver.
  • 2017 May;11(3):392-400.
  • doi: 10.5009/gnl16265
BACKGROUND/AIMS: MicroRNAs (miRNAs) regulate gene expression. We assess miRNA regulation by Helicobacter pylori infection and elucidate their role in H. pylori-infected gastric epithelial cells. METHODS: The relationship between miRNA expression and...
Differences in Prevalence of Lymphovascular Invasion among Early Gastric Cancers between Korea and Japan

Lee SY, Yoshida N, Dohi O, Lee SP, Ichikawa D, Kim JH, Sung IK, Park HS, Otsuji E, Itoh Y, Shim CS, Han HS, Kishimoto , Naito Y

  • Gut Liver.
  • 2017 May;11(3):383-391.
  • doi: 10.5009/gnl16281
BACKGROUND/AIMS: The presence of invasion is a diagnostic criterion of early gastric cancer (EGC) in Korea, whereas diagnosis in Japan is based on enlarged nuclei and prominent nucleoli. Moreover, the...
Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett's Esophagus

Lee SW, Lien HC, Lee TY, Tung CF, Yeh HZ, Chang CS

  • Gut Liver.
  • 2017 May;11(3):377-382.
  • doi: 10.5009/gnl16211
BACKGROUND/AIMS: The aim of this study was to investigate the associations between obesity and erosive esophagitis (EE) or Barrett's esophagus (BE) in a Chinese population. METHODS: Data from subjects were retrospectively...
Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life

Yoon JY, Shin JE, Park SH, Park DI, Cha JM

  • Gut Liver.
  • 2017 May;11(3):370-376.
  • doi: 10.5009/gnl16422
BACKGROUND/AIMS: The inflammatory bowel disease disability index (IBD-DI) was recently developed for IBD to assess the functional consequences and disease burden. We applied the IBD-DI to a Korean population and...
Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease

Han YM, Yoon H, Lim S, Sung MK, Shin CM, Park YS, Kim N, Lee DH, Kim JS

  • Gut Liver.
  • 2017 May;11(3):363-369.
  • doi: 10.5009/gnl16333
BACKGROUND/AIMS: Studies on the micronutrient status of Asian patients with inflammatory bowel disease (IBD) are scarce. We evaluated the prevalence of micronutrient deficiency and verified the risk factors for micronutrient...
Decreased Esophageal Sensitivity to Acid in Morbidly Obese Patients: A Cause for Concern?

Ortiz V, Alvarez-Sotomayor D, Sáez-González E, Díaz-Jaime FC, Iborra M, Ponce J, Garrigues

  • Gut Liver.
  • 2017 May;11(3):358-362.
  • doi: 10.5009/gnl16081
BACKGROUND/AIMS: To evaluate esophageal sensitivity to acid between morbidly obese (MO) patients and non-MO controls with abnormal esophageal acid exposure. METHODS: We conducted a cross-sectional study of 58 patients: 30 MO...
Functional Dyspepsia: Advances in Diagnosis and Therapy

Talley NJ

  • Gut Liver.
  • 2017 May;11(3):349-357.
  • doi: 10.5009/gnl16055
Functional dyspepsia (FD) is a common but under-recognized syndrome comprising bothersome recurrent postprandial fullness, early satiety, or epigastric pain/burning. Epidemiologically, there are two clinically distinct FD syndromes (although these often...
Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis

Toshikuni

  • Gut Liver.
  • 2017 May;11(3):335-348.
  • doi: 10.5009/gnl15458
Chronic hepatitis C virus (HCV) infection may eventually lead to liver cirrhosis (LC), a condition associated with a high risk of liver failure and hepatocellular carcinoma. Although interferon (IFN)-based therapy...
Obesity-Related Digestive Diseases and Their Pathophysiology

Nam SY

  • Gut Liver.
  • 2017 May;11(3):323-334.
  • doi: 10.5009/gnl15557
Obesity is a growing medical and public health problem worldwide. Many digestive diseases are related to obesity. In this article, the current state of our knowledge of obesity-related digestive diseases,...
Can Magnetic Resonance Elastography Fill a Niche in the Market for Noninvasive Assessment of Liver Fibrosis?

Kim SU

  • Gut Liver.
  • 2017 May;11(3):321-322.
  • doi: 10.5009/gnl16616
No abstract available.
Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease

Choi HH, Cho YS

  • Gut Liver.
  • 2017 May;11(3):319-320.
  • doi: 10.5009/gnl17103
No abstract available.
Micronutrients Should Be Monitored in the Real Practice for Korean Inflammatory Bowel Disease Patients

Kim SE

  • Gut Liver.
  • 2017 May;11(3):317-318.
  • doi: 10.5009/gnl17135
No abstract available.
Clinical Considerations of Silent Gastroesophageal Reflux Disease in Morbidly Obese Patients

Kim SE

  • Gut Liver.
  • 2017 May;11(3):315-316.
  • doi: 10.5009/gnl17084
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr